A2M and myeloid sarcoma: Following demyelination in human MS and rodent EAE, immunogenic MBP peptides are released into cerebrospinal fluid and serum (see Oksenberg and coworkers [2] for references) and A2M represents the major MBP-binding protein in human plasma [17].